| BAKER BROS. ADVISORS LP |
Director, 10%+ Owner |
$2,918,691,806 |
|
|
31 Dec 2025 |
| Herve Hoppenot |
Director |
$31,601,850 |
-$19,773,750 |
-38% |
08 Dec 2025 |
| PABLO J. CAGNONI |
President, R&D |
$14,287,580 |
|
|
14 Jul 2025 |
| Christiana Stamoulis |
EVP & Chief Financial Officer |
$7,652,435 |
|
|
14 Jul 2025 |
| Mohamed Khairie Issa |
EVP, Head of US Oncology |
$7,213,017 |
-$1,184,064 |
-14% |
06 Jan 2026 |
| PAULA J. SWAIN |
EVP, Human Resources |
$6,479,429 |
|
|
14 Jul 2025 |
| Wenqing Yao |
EVP, Head of Discovery Chem |
$6,062,363 |
|
|
02 Jul 2021 |
| Patrick A. Mayes |
EVP & Chief Scientific Officer |
$5,697,444 |
-$554,965 |
-8.9% |
10 Dec 2025 |
| Maria E. Pasquale |
EVP & General Counsel |
$4,288,026 |
|
|
14 Jul 2023 |
| Dashyant Dhanak |
EVP & Chief Scientific Officer |
$3,626,532 |
|
|
14 Jul 2023 |
| Steven H. Stein |
EVP & Chief Medical Officer |
$3,478,445 |
-$6,622,645 |
-66% |
05 Jan 2026 |
| Sheila A. Denton |
EVP & General Counsel |
$2,772,740 |
-$2,141,982 |
-44% |
17 Nov 2025 |
| Vijay K. Iyengar |
Evp, Gmapps |
$2,771,314 |
-$736,698 |
-21% |
16 Jul 2025 |
| Lee Heeson |
EVP, Head of Incyte Intl |
$2,749,238 |
-$289,017 |
-9.5% |
03 Nov 2025 |
| Michael James Morrissey |
EVP, Head of Tech. Operations |
$2,691,778 |
-$5,675,002 |
-68% |
31 Dec 2025 |
| Barry P. Flannelly |
EVP & General Manager US |
$2,402,785 |
-$2,258,571 |
-48% |
16 Jul 2025 |
| Paul J. Clancy |
Director |
$2,318,724 |
|
|
31 Dec 2025 |
| Thomas Tray |
Principal Accounting Officer |
$2,297,300 |
-$520,904 |
-18% |
18 Dec 2025 |
| Jonathan Elliott Dickinson |
EVP, General Manager, Europe |
$2,269,644 |
|
|
12 Sep 2024 |
| William Meury |
Chief Executive Officer, Director, President |
$2,196,745 |
|
|
02 Jul 2025 |
| EDMUND HARRIGAN |
Director |
$2,059,650 |
|
|
31 Dec 2025 |
| Paul Trower |
Principal Accounting Officer |
$1,984,482 |
|
|
19 Jan 2022 |
| JEAN JACQUES BIENAIME |
Director |
$1,268,174 |
|
|
10 Jun 2025 |
| JACQUALYN A. FOUSE |
Director |
$1,175,987 |
|
|
10 Jun 2025 |
| WENDY L. DIXON |
Director |
$1,092,732 |
|
|
31 Mar 2022 |
| Richard A. Hoffman |
EVP & General Counsel |
$997,811 |
|
|
01 Dec 2025 |
| Matteo Trotta |
EVP, GM, Dermatology US |
$913,723 |
|
|
15 Jul 2025 |
| Katherine A. High |
Director |
$811,799 |
|
|
10 Jun 2025 |
| David H. Gardner |
EVP, Chief Strategy Officer |
$789,207 |
|
|
22 Sep 2025 |
| OTIS W. BRAWLEY |
Director |
$684,684 |
|
|
10 Jun 2025 |
| Ramitpal K. Basi |
EVP, Human Resources |
$544,552 |
|
|
25 Aug 2025 |
| Susanne Schaffert |
Director |
$449,620 |
|
|
10 Jun 2025 |